Sensei Biotherapeutics, Inc.
SNSE
$7.96
$0.41395.49%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 2.67M | 3.55M | 2.13M | 3.19M | 3.20M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 5.21M | 7.27M | 6.62M | 7.82M | 7.79M |
Operating Income | -5.21M | -7.27M | -6.62M | -7.82M | -7.79M |
Income Before Tax | -4.94M | -6.86M | -7.77M | -7.25M | -7.14M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -4.94M | -6.86M | -7.77M | -7.25M | -7.14M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -4.94M | -6.86M | -7.77M | -7.25M | -7.14M |
EBIT | -5.21M | -7.27M | -6.62M | -7.82M | -7.79M |
EBITDA | -5.17M | -7.24M | -6.29M | -7.49M | -7.46M |
EPS Basic | -3.91 | -5.45 | -6.17 | -5.77 | -5.69 |
Normalized Basic EPS | -2.43 | -3.54 | -3.21 | -3.61 | -3.56 |
EPS Diluted | -3.91 | -5.45 | -6.17 | -5.77 | -5.69 |
Normalized Diluted EPS | -2.43 | -3.54 | -3.21 | -3.61 | -3.56 |
Average Basic Shares Outstanding | 1.26M | 1.26M | 1.26M | 1.26M | 1.26M |
Average Diluted Shares Outstanding | 1.26M | 1.26M | 1.26M | 1.26M | 1.26M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |